The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency. A Prospective, Multi-centre Study

Similar documents
Conflict of Interest. None

Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO

The role of ultrasound duplex in endovenous procedures

Patient assessment and strategy making for endovenous treatment

Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction. Erin H. Murphy, MD Rane Center

Vein Disease Treatment

What can we learn from randomized trials comparing endovenous and open surgery for primary varicosis? an overview Prof. Dr. Thomas M.

Image-Guided Approach to Treatment of Patients with Nonthrombotic

Endovascular vs Surgical Carotid Revascularisation

Medicare C/D Medical Coverage Policy

Chronic Venous Insufficiency Compression and Beyond

2017 Florida Vascular Society

Clinical/Duplex Evaluation of Varicose Veins: Who to Treat?

How to best approach chronic venous occlusions?

Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results

MOCA and GLUE: results and analyses of the RCTs

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN.

Additional Information S-55

MR and CT venography for imaging venous obstruction

Criteria For Medicare Members. Kaiser Foundation Health Plan of Washington

VIRTUS: Trial Design and Primary Endpoint Results

Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD

LINC, Christine Teichert, MD University Medicine of Rostock, Dept. of diagnostic and interventional radiology, Germany

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY

Venous Reflux Duplex Exam

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015

Epidemiology: Prevalence

Klippel - Trenaunay Syndrome (KTS) When and What to do? Dr. Ayhan ŞENOL SBU.Gazi Yasargil ETH. Diyarbakır /TURKEY

Priorities Forum Statement

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019

Endothermal Ablation for Venous Insufficiency. Dr. S. Kundu Medical Director The Vein Institute of Toronto

Complex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

Original Policy Date

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Endo-Thermal Heat Induced Thrombosis (E-HIT)

VeClose trial Cyanoacylate closure vs. RF ablation 36-month results

Current Management of Varicose Veins

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Treatment of Varicose Veins/Venous Insufficiency. Description

Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous vein

Starting with deep venous treatment

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Chronic Venous Insufficiency

Selection and work up for the right patients suspected of deep venous disease

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Introduction to Saphenous Vein Ablations: When/Why/How?

New Guideline in venous ulcer treatment: dressing, medication, intervention

Carotid Artery Stenting

Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue)

Guidelines, Policies and Statements D20 Statement on Peripheral Venous Ultrasound

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

COMMISSIONING POLICY

PROVIDER POLICIES & PROCEDURES

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY

Le varici recidive Recurrent varices: how to manage them?

Treatment of Varicose Veins/Venous Insufficiency Corporate Medical Policy

Protocols for the evaluation of lower extremity venous reflux: supine, sitting, or standing?

Peripheral Arterial Disease: A Practical Approach

Abstracts Vaeshartelt 14 mei 2011 Résumés Vaeshartelt mai 2011

Micromesh technology in carotid artery treatment what is next? Max Amor MD Clinique Louis Pasteur, Essey-Les-Nancy France

Treatment of Varicose Veins/Venous Insufficiency

Clinical case. Symptomatic anterior accessory great saphenous vein (AAGSV) reflux

OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009

ACP Phlebology Fellowship Curriculum 1

Clinical Outcomes Among Vascular Procedure Patients Receiving Suture-mediated vs Surgical Cutdown for Closure of Large-bore Arterial Access

How do I use mechanical debulking for the treatment of arterial occlusions

Srovnání 2 typů radiálních laserových vláken (1-ringových a 2-ringových) v nitrožilní léčbě křečových žil pomocí laseru o vlnové délce 1470 nm

Lower Limb Venous Ultrasound. Colin P. Griffin MSc, BSc (Hons)

On Which Criteria Do You Select Your Stent for Ilio-femoral Venous Obstruction? North American Point of View

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Varicose veins. Natural history, assessment and management. Arteries and veins. Why do people get varicose veins? Classification of venous disease

Why Tumescent-Free Therapy Will Replace RF and Laser

WHAT ABOUT FOAM SCLEROTHERAPY IN REVAS? Dr O CRETON Ste FOY LES LYON

Bifurcation stenting with BVS

Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis

The evidence for venous interventions is evolving- many patients do actually benefit. Nils Kucher University Hospital Bern Switzerland

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts

DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality

Recurrent Varicose Veins We All See Them

A treatment option for varicose veins. enefit" Targeted Endovenous Therapy. Formerly known as the VNUS Closure procedure E 3 COVIDIEN

2-YEAR DATA SUPERA POPLITEAL REAL WORLD

A A U

Medical Policy. Description/Scope. Position Statement

Kathleen Gibson, MD FACS Lake Washington Vascular Surgeons, Bellevue, WA, USA

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Chapter 4 Section 9.1

A transvenous intravascular ultrasound-guided technique for chronic total occlusion of a below-the-knee artery

Ultrasound-assisted catheter-directed thrombolysis: Does it really work? The BERNUTIFUL trial

The Fate of Unexpected Events Occurring in Standard EVAR

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany

BC Vascular Surgery Day

Vascular Surgery and Transplant Unit University of Catania. Pierfrancesco Veroux

Transcription:

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency A Prospective, Multi-centre Study Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor of Vascular Surgery University of New South Wales Sydney, Australia

Disclosure Speaker name:...ramon L. Varcoe... I have the following potential conflicts of interest to report: Consulting: Medtronic, Abbott Vascular, Boston Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s) I do not have any potential conflict of interest

Ultrasound for Saphenous Vein Rx High quality Real-time imaging Without radiation Guide venous access Visualise ablation catheter Tumescence

? Limitations of Ultrasound Anatomical complexities Venous strictures Duplicate saphenous systems Severe tortuosity Segmental occlusions Aneurysms Venous confluence deep within the leg

Prospective, Multi-Centre design Study Design Inclusion Criteria >18 yo CEAP 2-6 Great-, small-, inter-saphenous or perforator ablation (RFA or CAE) Sonographic reflux >0.5 sec Exclusion Criteria Pregnant patients Contrast allergy Renal impairment Those undergoing: Surgical ligation/stripping Simple phlebectomy Pelvic embolization Rx for May-Thurner syndrome

Prospective, Multi-Centre design Study Design Inclusion Criteria >18 yo CEAP 2-6 Great-, small-, inter-saphenous or perforator ablation (RFA or CAE) Sonographic reflux >0.5 sec Exclusion Criteria Pregnant patients Contrast allergy Renal impairment Those undergoing: Surgical ligation/stripping Simple phlebectomy Pelvic embolization Rx for May-Thurner syndrome

Prospective, Multi-Centre design Study Design Inclusion Criteria >18 yo CEAP 2-6 Great-, small-, inter-saphenous or perforator ablation (RFA or CAE) Sonographic reflux >0.5 sec Exclusion Criteria Pregnant patients Contrast allergy Renal impairment Those undergoing: Surgical ligation/stripping Simple phlebectomy Pelvic embolization Rx for May-Thurner syndrome

Prospective, Multi-Centre design Inclusion Criteria >18 yo CEAP 2-6 Great-, small-, inter-saphenous or perforator ablation (RFA or CAE) Sonographic reflux >0.5 sec 305 Venous trunks 268 Limbs 200 Patients Study Design Exclusion Criteria Pregnant patients Contrast allergy Renal impairment Those undergoing: Surgical ligation/stripping Simple phlebectomy Pelvic embolization Rx for May-Thurner syndrome October 2010 to May 2016

Patient Demographics n = 200 Age (mean ± SD, range) 60.9 ± 12.9 (33-86) Women 128 (64%) Number of legs treated 268 Number of saphenous trunks 305 Treatment Indication Primary varicose veins 169 (85%) Recurrent varicose veins 23 (12%) Thrombophlebitis 2 (1%) Ulceration 6 (3%) CEAP Classification C2 Varicose veins 85 (43%) C3 Oedema 65 (33%) C4 Skin changes 30 (15%) C5 Healed ulcer 5 (3%) C6 Active ulcer 12 (6%)

Patient Demographics n = 200 Age (mean ± SD, range) 60.9 ± 12.9 (33-86) Women 128 (64%) Number of legs treated 268 Number of saphenous trunks 305 Treatment Indication Primary varicose veins 169 (85%) Recurrent varicose veins 23 (12%) Thrombophlebitis 2 (1%) Ulceration 6 (3%) CEAP Classification C2 Varicose veins 85 (43%) C3 Oedema 65 (33%) C4 Skin changes 30 (15%) C5 Healed ulcer 5 (3%) C6 Active ulcer 12 (6%)

Patient Demographics n = 200 Age (mean ± SD, range) 60.9 ± 12.9 (33-86) Women 128 (64%) Number of legs treated 268 Number of saphenous trunks 305 Treatment Indication Primary varicose veins 169 (85%) Recurrent varicose veins 23 (12%) Thrombophlebitis 2 (1%) Ulceration 6 (3%) CEAP Classification C2 Varicose veins 85 (43%) C3 Oedema 65 (33%) C4 Skin changes 30 (15%) C5 Healed ulcer 5 (3%) C6 Active ulcer 12 (6%)

Insufficient Vein n = 305 Great saphenous 241 (79%) Small Saphenous 38 (13%) Anterior accessory great saphenous 6 (2%) Inter-saphenous (Giacomini) 10 (3%) Perforator 10 (3%)

542 runs Mean 2.0/limb Median 1.0/limb Venography Mean Time: 4.9 ±9.1 min (range 1-48) Nil contrast related morbidity* *CIN, Anaphylaxis, Anaphylactoid reactions

Venous Anomalies in 66%

Venous Anomalies in 66% Duplicate System 33%

Venous Anomalies in 66% Duplicate System Aneurysm 33% 28%

Venous Anomalies in 66% Duplicate System Aneurysm Stenosis 33% 28% 21%

Venous Anomalies in 66% Duplicate System Aneurysm Stenosis Large Incompetent Perforator 33% 28% 21% 11%

Venous Anomalies in 66% Duplicate System Aneurysm Stenosis Large Incompetent Perforator Saphenous Occlusion 33% 28% 21% 11% 4%

Venous Anomalies in 66% Duplicate System Aneurysm Stenosis Large Incompetent Perforator Saphenous Occlusion Filling Defect (Thrombus) 33% 28% 21% 11% 4% 3%

Adjunctive Manoeuvres in 44%

Adjunctive Manoeuvres in 44% Manoeuvre n = 200 Use of a low profile guide wire and angled catheter 53 (27%)

Use of a low profile guide wire and angled catheter 27% *

Adjunctive Manoeuvres in 44% Manoeuvre n = 200 Use of a low profile guide wire and angled catheter 53 (27%) Use of additional RFA or CAE in dilated segment 30 (15%)

Use of additional RFA or CAE in dilated segment 15%

Adjunctive Manoeuvres in 44% Manoeuvre n = 200 Use of a low profile guide wire and angled catheter 53 (27%) Use of additional RFA or CAE in dilated segment 30 (15%) Simultaneous treatment of multiple incompetent saphenous vein trunks 4 (2%) Selective cannulation of an incompetent saphenous vein 24 (12%)

Selective Cannulation in 12% Treated multiple Trunks in 2%

Adjunctive Manoeuvres in 44% Manoeuvre n = 200 Use of a low profile guide wire and angled catheter 53 (27%) Use of additional RFA or CAE in dilated segment 30 (15%) Simultaneous treatment of multiple incompetent saphenous vein trunks 4 (2%) Selective cannulation of an incompetent saphenous vein Fluoroscopic guidance to negotiate the superficialdeep-vein junction Fluoroscopic guidance to position the radiofrequency probe 24 (12%) 6 (3%) 27 (14%)

Fluoroscopic guided probe positioning in 14%

Self Reported Rate of 34/200 (17%) UNABLE TO COMPLETE Rx WITHOUT XRAY Where the operator felt that the procedure would have to be left incomplete or converted to foam without an endovascular manoeuvre.

Self Reported Rate of 34/200 (17%) Required Manoeuvre n = 34 Selective cannulation of an incompetent saphenous 14 (41%) trunk required Severe Tortuosity 13 (38%) Stenosis Preventing Passage of Probe/Catheter 9 (27%) Occluded Saphenous Vein (with an incompetent proximal segment) 5 (15%)

Based on mean 2.0 runs/limb 0.74 msv/limb Risk 1 in 36,000 fatal cancer * Source: Australian Radiation Protection and Nuclear Safety Agency

Based on mean 2.0 runs/limb 0.74 msv/limb Risk 1 in 36,000 fatal cancer Compared with 1.5 msv - a year s environmental exposure 1-5 msv CT Brain 5-10 msv Coronary angiography >10 msv CT Abdo/Pelvis (multi-phase) * Source: Australian Radiation Protection and Nuclear Safety Agency

Based on mean 2.0 runs/limb 0.74 msv/limb Risk 1 in 36,000 fatal cancer Compared with 1.5 msv - a year s environmental exposure 1-5 msv CT Brain 5-10 msv Coronary angiography >10 msv CT Abdo/Pelvis (multi-phase) Thorough treatment Less failures Less foam conversion Less recurrence * Source: Australian Radiation Protection and Nuclear Safety Agency

Summary A significant number of venous anomalies go unrecognised by standard duplex imaging A number of those (44%) benefit from x-ray guided endovascular assistance Without that assistance 1 in 5 will be left with incomplete treatment or converted to foam There is definite value in using x-ray guidance in selected patients

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency A Prospective, Multi-centre Study Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor of Vascular Surgery University of New South Wales Sydney, Australia

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency A Prospective, Multi-centre Study Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor of Vascular Surgery University of New South Wales Sydney, Australia